The PRECISE-DAPT Score was developed to predict the risk of bleeding in patients treated with dual antiplatelet therapy (i.e. aspirin plus a P2Y12 inhibitor). The Score was developed from a collaborative dataset including data from 8 randomized clinical trials. Bleeding events were defined according to the Thrombosis in myocardial infarction (TIMI) bleeding definition.
The PRECISE-DAPT Score and all related materials are for exclusive use of health care professionals and is intended as a supportive risk assessment tool which should never replace clinical judgment, physician–patient relationship or medical advice.
Treatment risks and benefits should always be considered in the context of a comprehensive professional clinical assessment, taking into account all available data and treatment options. Physicians and other healthcare providers should always exercise their own clinical judgment for any given situation.
Terms of service for email reporting